Sleep well, knowing
you’ll have the financial
resources to live well

Performance



Daily Prices

Series Current NAVPS Prior NAVPS NAVPS Change Net Asset Value Last Updated
A $ 13.6537 $ 13.5077 1.08% $ 19,234,011 2018-02-16
*B $ 12.9552 $ 12.8169 1.08% $ 257,422 2018-02-16
F $ 15.0960 $ 14.9342 1.08% $ 5,304,153 2018-02-16
T8A $ 6.1627 $ 6.0968 1.08% $ 402,441 2018-02-16
L $ 17.2751 $ 17.0906 1.08% $ 6,275,965 2018-02-16
* Closed to new purchases.

Series Rolling Returns (%)

Series 1 Month 3 Month 6 Month Year To Date 1 Year 3 Year 5 Year 10 Year Since Inception Inception Date
A 1.4 0.6 3.0 1.4 16.6 2.8 8.6 n/a 3.5 2008-05-31
B 1.3 0.5 2.7 1.3 15.9 2.2 7.9 n/a 3.0 2008-05-31
F 1.5 1.0 3.7 1.5 18.2 4.0 9.8 n/a 4.6 2008-05-31
L 1.3 0.5 2.7 1.3 15.9 2.2 8.0 n/a 9.2 2011-09-01
T8A 1.4 0.6 3.0 1.4 16.5 2.8 8.5 n/a 3.4 2008-05-31

Calendar Returns

CALENDAR RETURN 20172016201520142013201220112010200920082007
A 11.9 (10.4) 17.7 3.3 27.2 15.6 (0.1) (6.6) 13.1 (27.0)
B 11.1 (11.0) 17.1 2.7 26.4 14.9 (0.2) (7.1) 12.6 (27.2)
C 2.8 26.4 14.8 (0.3) (7.1) 12.6 (27.2)
F 13.4 (9.5) 18.9 4.4 28.5 16.9 0.4 (5.6) 14.1 (26.5)
T8A 11.7 (10.6) 17.8 3.3 27.1 15.7 0.1 (6.7) 12.4 (27.0)
T8B 2.9 26.8 15.0 (0.2) (7.1) 12.6 (27.2)
T8C 14.8 (0.3) (7.1) 12.4 (27.2)
L 11.1 (11.0) 17.2 2.8 26.6 15.0 (0.2)
Benchmark 16.9 (2.8) 15.7 2.5 33.8 16.6 (9.1) (1.2) 16.7 (32.3)

Growth of $10,000 Since Inception

Portfolio Composition (%)

Top Holdings (%)

HOLDINGS
1 Novartis AG, Registered 5.2
2 Reckitt Benckiser 5.0
3 Sampo Group 4.7
4 Cerved Information Solutions SpA 4.3
5 Kinepolis Group NV 4.3
6 Reed Elsevier plc 4.2
7 Givaudan SA, Reg. 4.2
8 Anheuser-Busch InBev NV 4.1
9 AstraZeneca PLC 4.0
10 Rubis 4.0
Total 44%

Fund Management Expense Ratio As of 12/31/2016

A B F L T8A
2.81 3.46 1.79 3.40 2.95
Stone Co